#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4422437	T	Toxicity in athymic nude mouse xenografted with human SK-MEL-103 cells assessed as induction of distress at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation and measured on day 16	Mus musculus	1	ALA4421731	organism-based format	Patent Bioactivity Data
2.	ALA4422438	F	Effect on general transcription in HO-null-c-Myc deficient rat Rat1A cells assessed as inhibition of cell growth incubated for 72 hrs by methylene blue staining based assay	Rattus norvegicus	18	ALA4421731	assay format	Patent Bioactivity Data
3.	ALA4422439	B	Inhibition of N-Myc (unknown origin) expressed in rat Rat1A cells assessed as inhibition of cell growth incubated for 72 hrs by methylene blue staining based assay	Homo sapiens	25	ALA4421731	cell-based format	Patent Bioactivity Data
4.	ALA4422440	B	Inhibition of C-Myc (unknown origin) expressed in rat Rat1A cells assessed as inhibition of cell growth incubated for 72 hrs by methylene blue staining based assay	Homo sapiens	25	ALA4421731	cell-based format	Patent Bioactivity Data
5.	ALA4422441	U	Selectivity index, ratio of ID50 for growth inhibition of HO-null-c-Myc deficient rat Rat1A cells incubated for 72 hrs by methylene blue staining based assay to ID50 for inhibition of N-Myc (unknown origin) expressed in rat Rat1A cells assessed as inhibition of cell growth incubated for 72 hrs by methylene blue staining based assay		18	ALA4421731	cell-based format	Patent Bioactivity Data
6.	ALA4422442	U	Selectivity index, ratio of ID50 for growth inhibition of HO-null-c-Myc deficient rat Rat1A cells incubated for 72 hrs by methylene blue staining based assay to ID50 for inhibition of c-Myc (unknown origin) expressed in rat Rat1A cells assessed as inhibition of cell growth incubated for 72 hrs by methylene blue staining based assay		18	ALA4421731	cell-based format	Patent Bioactivity Data
7.	ALA4422443	B	Inhibition of Myc in human melanoma cells assessed as increase in Myc-repressed p27kip1 gene expression	Homo sapiens	8	ALA4421731	cell-based format	Patent Bioactivity Data
8.	ALA4422444	B	Inhibition of Myc in human melanoma cells assessed as reduction in in Myc-transactivated thymidylate synthase gene expression	Homo sapiens	8	ALA4421731	cell-based format	Patent Bioactivity Data
9.	ALA4422454	F	Antitumor activity against human melanoma cells xenografted in mouse assessed as inhibition of tumor growth measured up to 8 days	Homo sapiens	1	ALA4421731	cell-based format	Patent Bioactivity Data
10.	ALA4422455	T	Toxicity in mouse xenografted with human melanoma cells measured up to 8 days	Mus musculus	1	ALA4421731	assay format	Patent Bioactivity Data
11.	ALA4422456	F	Growth inhibition of human SK-MEL-19 cells	Homo sapiens	8	ALA4421731	cell-based format	Patent Bioactivity Data
12.	ALA4422457	F	Growth inhibition of human SK-MEL-103 cells	Homo sapiens	8	ALA4421731	cell-based format	Patent Bioactivity Data
13.	ALA4422458	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as inhibition of tumor growth at 50 mg/kg, ip dosed daily	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
14.	ALA4422459	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as improvement in mouse survival at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
15.	ALA4422460	T	Toxicity in athymic nude mouse xenografted with human SK-MEL-103 cells assessed as induction of weight loss at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation	Mus musculus	1	ALA4421731	organism-based format	Patent Bioactivity Data
16.	ALA4422461	T	Toxicity in athymic nude mouse xenografted with human SK-MEL-103 cells assessed as induction of sickness at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation and measured on day 16	Mus musculus	1	ALA4421731	organism-based format	Patent Bioactivity Data
17.	ALA4422462	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as improvement in mouse survival at 50 mg/kg, ip dosed daily for 4 days dosed via Captisol formulation	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
18.	ALA4422463	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as inhibition of tumor growth at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
19.	ALA4422464	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as increase in doubling time for tumor growth at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
20.	ALA4422465	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as growth delay time in reaching study end point (1000 mm3 tumor growth) at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data